Dear John,

ICYMI, Stephen Crystal of Rutgers University appeared on A Health Podyssey to discuss his recent paper exploring how states with substantial increases in buprenorphine uptake as an opioid use disorder treatment response grew alongside increased Medicaid prescribing from 2018–24.

This week, a second generic option for the abortion pill mifepristone was approved by the FDA.

For Flashback Friday, let's take a look at what Health Affairs has published on the topic of reproductive health.

Tubal Sterilization And Vasectomy Increased Among US Young Adults After The Dobbs Supreme Court Decision In 2022

Julia Strasser et al. (January 2025)

Title X Improved Access To Most Effective And Moderately Effective Contraception In US Safety-Net Clinics, 2016–18

Blair G. Darney et al. (April 2022)

Twelve-Month Contraception Dispensing Advances Access And Equity

Sarah Lee Day et al. (April 2023)

The Need For Accurate Contraceptive Awareness And Advocacy Among Health Care Providers

Jenny A. Higgins et al. (March 2021)

Today's Featured Articles

Physician Autonomy in Decline: The Rise of Deprofessionalization w/ Yul Ejnes

Health Affairs' Jeff Byers welcomes Dr. Yul Ejnes of Brown University Health to the pod to discuss a recent Forefront article he authored about the trend of deprofessionalization in the health care workforce and potential antidotes to address these issues.

Major Lawsuit Over Medication Abortion To Move From Texas To Missouri

Katie Keith

part of our Health Policy At A Crossroads series

Can AI Help Deliver CMS’s Value-Based Care Agenda?

Michael S. Barr

part of our Accountable Care For Population Health series

From Promise To Practice: Delivering On The WHO Pandemic Agreement

Xiaoshun Li et al.

LIVE with Jennifer Kao on the Risk Evaluation On Generic Approvals Of US Pharmaceuticals

Join us for a free live taping of A Health Podyssey on October 22 where Jennifer Kao will discuss her upcoming paper exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.